Doyle Mittie

CIK: 0001918845
Director

Doyle Mittie is a corporate insider at Avalo Therapeutics, Inc. (AVTX) filing SEC Form 4 transactions. 26 transactions across 3 companies. Source: SEC EDGAR.

Total Transactions
26
Total Buy Value
$0
Total Sell Value
$0
Net Activity
$0
Last Transaction
Sep 2026
Companies
3

Companies

Transaction History

Source: SEC EDGAR Form 4 insider transaction filings.

Type
Exercise
Shares
679
Price
$8.04
Value
$5K
Type
Sale
Shares
679
Price
$20.00
Value
$14K
Type
Exercise
Shares
679
Price
$8.04
Value
$5K
Type
Exercise
Shares
1,000
Price
$12.65
Value
$13K
Type
Sale
Shares
1,000
Price
$20.00
Value
$20K
Type
Exercise
Shares
1,000
Price
$12.65
Value
$13K
Type
Exercise
Shares
1,450
Price
$8.04
Value
$12K
Type
Sale
Shares
1,450
Price
$18.00
Value
$26K
Type
Exercise
Shares
1,450
Price
$8.04
Value
$12K
Type
Exercise
Shares
3,970
Price
$12.65
Value
$50K
Type
Sale
Shares
3,970
Price
$18.01
Value
$72K
Type
Exercise
Shares
3,970
Price
$12.65
Value
$50K
Type
Exercise
Shares
679
Price
$8.04
Value
$5K
Type
Sale
Shares
679
Price
$16.00
Value
$11K
Type
Exercise
Shares
679
Price
$8.04
Value
$5K
Type
Exercise
Shares
5,992
Price
$8.04
Value
$48K
Type
Exercise
Shares
19,500
Price
$12.65
Value
$247K
Type
Sale
Shares
25,492
Price
$16.15
Value
$412K
Type
Exercise
Shares
5,992
Price
$8.04
Value
$48K
Type
Exercise
Shares
19,500
Price
$12.65
Value
$247K